MOESM1 of Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa

Evans, Denise; Hirasen, Kamban; Berhanu, Rebecca; Malete, Given; Ive, Prudence; Spencer, David; Badal-Faesen, Sharlaa; Sanne, Ian; Fox, Matthew

doi:10.6084/m9.figshare.6126089.v1

12981_2018_196_MOESM1_ESM.docx (11.59 kB)

MOESM1 of Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa

journal contribution

posted on 2018-04-10, 05:00 authored by Denise Evans, Kamban Hirasen, Rebecca Berhanu, Given Malete, Prudence Ive, David Spencer, Sharlaa Badal-Faesen, Ian Sanne, Matthew Fox

Additional file 1: Table S1. Summary of third-line patients transferred in from clinical trials (n=10).

Funding

United States Agency for International Development South Africa

History

Usage metrics

Keywords

Third-line ART Virologic response Resource-limited setting South Africa

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM1 of Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa

Funding

United States Agency for International Development South Africa

History

Usage metrics

Categories

Keywords

Licence

Exports